NASDAQ:MGLN - Magellan Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$75.65 +1.60 (+2.16 %)
(As of 08/21/2018 03:43 PM ET)
Previous Close$74.30
Today's Range$74.30 - $75.65
52-Week Range$71.03 - $112.25
Volume5,737 shs
Average Volume343,403 shs
Market Capitalization$1.83 billion
P/E Ratio13.46
Dividend YieldN/A
Beta0.4
Magellan Health logoMagellan Health, Inc. provides healthcare management services in the United States. It operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine for health plans, care organizations, and employers. It also contracts with local, state, and federal governmental agencies to provide services to recipients under Medicaid, Medicare, and other government programs, such as behavioral health and EAP, as well as healthcare management and long term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. This segment offers pharmacy benefit management services, pharmacy benefit administration for state Medicaid and other government sponsored programs, pharmaceutical dispensing services, clinical and formulary management programs, medical pharmacy management programs, and programs for the integrated management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is headquartered in Scottsdale, Arizona.

Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Hospitals
Sub-IndustryManaged Health Care
SectorMedical
SymbolNASDAQ:MGLN
CUSIP55907920
Phone602-572-6050

Debt

Debt-to-Equity Ratio0.56
Current Ratio1.63
Quick Ratio1.58

Price-To-Earnings

Trailing P/E Ratio13.46
Forward P/E Ratio16.63
P/E Growth1.64

Sales & Book Value

Annual Sales$5.84 billion
Price / Sales0.32
Cash Flow$10.7305 per share
Price / Cash7.05
Book Value$53.09 per share
Price / Book1.42

Profitability

EPS (Most Recent Fiscal Year)$5.50
Net Income$110.20 million
Net Margins1.66%
Return on Equity11.29%
Return on Assets4.86%

Miscellaneous

Employees10,700
Outstanding Shares24,560,000
Market Cap$1.83 billion

Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

How were Magellan Health's earnings last quarter?

Magellan Health Inc (NASDAQ:MGLN) issued its quarterly earnings results on Friday, July, 27th. The company reported $0.91 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $1.06 by $0.15. The business earned $1.81 billion during the quarter, compared to the consensus estimate of $1.88 billion. Magellan Health had a return on equity of 11.29% and a net margin of 1.66%. The business's quarterly revenue was up 27.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.59 earnings per share. View Magellan Health's Earnings History.

When is Magellan Health's next earnings date?

Magellan Health is scheduled to release their next quarterly earnings announcement on Wednesday, November, 7th 2018. View Earnings Estimates for Magellan Health.

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health issued an update on its FY18 earnings guidance on Friday, July, 27th. The company provided earnings per share guidance of $5.18-5.96 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.24. The company issued revenue guidance of $7.3-7.5 billion, compared to the consensus revenue estimate of $7.59 billion.

What price target have analysts set for MGLN?

4 brokerages have issued 1 year target prices for Magellan Health's stock. Their predictions range from $85.00 to $105.00. On average, they expect Magellan Health's share price to reach $94.6667 in the next twelve months. This suggests a possible upside of 26.3% from the stock's current price. View Analyst Price Targets for Magellan Health.

What is the consensus analysts' recommendation for Magellan Health?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Magellan Health.

Who are some of Magellan Health's key competitors?

Who are Magellan Health's key executives?

Magellan Health's management team includes the folowing people:
  • Mr. Barry Morgan Smith, Chairman & CEO (Age 64)
  • Mr. Jonathan Neal Rubin, Chief Financial Officer (Age 54)
  • Mr. Daniel N. Gregoire, Gen. Counsel & Sec. (Age 62)
  • Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 37)
  • Ms. Renie Shapiro Silver, SVP - Corp. Fin.

Has Magellan Health been receiving favorable news coverage?

Headlines about MGLN stock have been trending somewhat positive on Tuesday, according to Accern Sentiment. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Magellan Health earned a media and rumor sentiment score of 0.15 on Accern's scale. They also assigned press coverage about the company an impact score of 41.07 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View Recent Headlines for Magellan Health.

Who are Magellan Health's major shareholders?

Magellan Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.14%), FMR LLC (8.88%), Dimensional Fund Advisors LP (8.35%), Renaissance Technologies LLC (4.04%), Fisher Asset Management LLC (2.72%) and Victory Capital Management Inc. (2.28%). Company insiders that own Magellan Health stock include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Eran Broshy, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health.

Which major investors are selling Magellan Health stock?

MGLN stock was sold by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, Hood River Capital Management LLC, Millennium Management LLC, Wells Fargo & Company MN, DnB Asset Management AS, LSV Asset Management, Renaissance Technologies LLC and Alambic Investment Management L.P.. Company insiders that have sold Magellan Health company stock in the last year include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Insider Buying and Selling for Magellan Health.

Which major investors are buying Magellan Health stock?

MGLN stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, BlackRock Inc., Brown Advisory Inc., Victory Capital Management Inc., Point72 Asset Management L.P., Dimensional Fund Advisors LP, WINTON GROUP Ltd and Cambiar Investors LLC. View Insider Buying and Selling for Magellan Health.

How do I buy shares of Magellan Health?

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $74.95.

How big of a company is Magellan Health?

Magellan Health has a market capitalization of $1.83 billion and generates $5.84 billion in revenue each year. The company earns $110.20 million in net income (profit) each year or $5.50 on an earnings per share basis. Magellan Health employs 10,700 workers across the globe.

How can I contact Magellan Health?

Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected]


MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  258 (Vote Outperform)
Underperform Votes:  256 (Vote Underperform)
Total Votes:  514
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe MGLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/21/2018 by MarketBeat.com Staff

Featured Article: How Short Selling Works

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel